{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T22:40:26Z","timestamp":1775083226299,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1053\/j.seminoncol.2007.05.006","type":"journal-article","created":{"date-parts":[[2007,8,4]],"date-time":"2007-08-04T11:11:35Z","timestamp":1186225895000},"page":"321-326","source":"Crossref","is-referenced-by-count":8,"title":["Adjuvant Therapy for Pancreas Cancer: Advances and Controversies"],"prefix":"10.1053","volume":"34","author":[{"given":"Mary F.","family":"Mulcahy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminoncol.2007.05.006_bib1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","article-title":"Cancer statistics, 2007","volume":"57","author":"Jemal","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"10.1053\/j.seminoncol.2007.05.006_bib2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0039-6060(97)90264-6","article-title":"Pain as a predictor of outcome in patients with operable pancreatic carcinoma","volume":"122","author":"Kelsen","year":"1997","journal-title":"Surgery"},{"key":"10.1053\/j.seminoncol.2007.05.006_bib3","series-title":"AJCC Cancer Staging Manual","year":"2002"},{"key":"10.1053\/j.seminoncol.2007.05.006_bib4","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s11938-005-0040-x","article-title":"Borderline resectable pancreatic cancer","volume":"8","author":"Varadhachary","year":"2005","journal-title":"Curr Treat Options Gastroenterol"},{"key":"10.1053\/j.seminoncol.2007.05.006_bib5","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1091-255X(00)80071-2","article-title":"Is CT angiography sufficient for prediction of resectability of periampullary neoplasms?","volume":"4","author":"Saldinger","year":"2000","journal-title":"J Gastrointest Surg"},{"key":"10.1053\/j.seminoncol.2007.05.006_bib6","doi-asserted-by":"crossref","first-page":"821","DOI":"10.2214\/ajr.178.4.1780821","article-title":"Dual-phase helical CT of pancreatic adenocarcinoma: Assessment of resectability before surgery","volume":"178","author":"Valls","year":"2002","journal-title":"AJR"},{"key":"10.1053\/j.seminoncol.2007.05.006_bib7","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2214\/ajr.173.3.10470884","article-title":"Dynamic contrast-enhanced MR imaging and dual-phase helical CT in the preoperative assessment of suspected pancreatic cancer: A comparative study with receiver operating characteristic analysis","volume":"173","author":"Sheridan","year":"1999","journal-title":"AJR"},{"key":"10.1053\/j.seminoncol.2007.05.006_bib8","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1159\/000055872","article-title":"Accuracy of endoscopic ultrasound in diagnosing and staging pancreatic carcinoma","volume":"1","author":"Wiersema","year":"2001","journal-title":"Pancreatology"},{"key":"10.1053\/j.seminoncol.2007.05.006_bib9","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S1091-255X(02)00150-6","article-title":"Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration in patients with presumed pancreatic cancer","volume":"7","author":"Raut","year":"2003","journal-title":"J Gastrointest Surg"},{"key":"10.1053\/j.seminoncol.2007.05.006_bib10","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/BF02985577","article-title":"Contribution of whole body FDG-PET to the detection of distant metastasis in pancreatic cancer","volume":"19","author":"Nishiyama","year":"2005","journal-title":"Ann Nucl Med"},{"key":"10.1053\/j.seminoncol.2007.05.006_bib11","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1007\/s002689900614","article-title":"Laparoscopy and laparoscopic ultrasonography for staging pancreatic cancer: Critical appraisal","volume":"23","author":"Pietrabissa","year":"1999","journal-title":"World J Surg"},{"key":"10.1053\/j.seminoncol.2007.05.006_bib12","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/bjs.1800820839","article-title":"Further experience with laparoscopy and peritoneal cytology in the staging of pancreatic cancer","volume":"82","author":"Fernandez-del Castillo","year":"1995","journal-title":"Br J Surg"},{"key":"10.1053\/j.seminoncol.2007.05.006_bib13","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1159\/000087497","article-title":"Preoperative assessment of pancreatic tumors using magnetic resonance imaging, endoscopic ultrasonography, positron emission tomography and laparoscopy","volume":"5","author":"Borbath","year":"2005","journal-title":"Pancreatology"},{"key":"10.1053\/j.seminoncol.2007.05.006_bib14","first-page":"384","article-title":"Recurrence of exocrine pancreatic cancer\u2014Local or hepatic?","volume":"40","author":"Westerdahl","year":"1993","journal-title":"Hepatogastroenterology"},{"key":"10.1053\/j.seminoncol.2007.05.006_bib15","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/1097-0142(19900701)66:1<56::AID-CNCR2820660112>3.0.CO;2-6","article-title":"Patterns of failure after curative resection of pancreatic carcinoma","volume":"66","author":"Griffin","year":"1990","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2007.05.006_bib16","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1001\/archsurg.1985.01390320023003","article-title":"Pancreatic cancer","volume":"120","author":"Kalser","year":"1985","journal-title":"Arch Surg"},{"key":"10.1053\/j.seminoncol.2007.05.006_bib17","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1002\/1097-0142(19870615)59:12<2006::AID-CNCR2820591206>3.0.CO;2-B","article-title":"Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer","volume":"59","year":"1987","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2007.05.006_bib18","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/0360-3016(93)90967-Z","article-title":"Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation +\/- 5 fluorouracil","volume":"26","author":"Foo","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1053\/j.seminoncol.2007.05.006_bib19","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/00000658-199705000-00018","article-title":"Pancreaticoduodenectomy for pancreatic adenocarcinoma: Postoperative adjuvant chemoradiation improves survival","volume":"225","author":"Yeo","year":"1997","journal-title":"Ann Surg"},{"key":"10.1053\/j.seminoncol.2007.05.006_bib20","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1067\/msy.1998.91487","article-title":"Molecular metastases in stage I pancreatic cancer: Improved survival with adjuvant chemoradiation","volume":"124","author":"Demeure","year":"1998","journal-title":"Surgery"},{"key":"10.1053\/j.seminoncol.2007.05.006_bib21","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/S0360-3016(00)00774-4","article-title":"Adjuvant radiotherapy and concomitant 5-fluorouracil by protracted venous infusion for resected pancreatic cancer","volume":"48","author":"Mehta","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1053\/j.seminoncol.2007.05.006_bib22","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/00000658-199912000-00006","article-title":"Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: Phase III trial of the EORTC Gastrointestinal Tract Cancer Cooperative Group","volume":"230","author":"Klinkenbijl","year":"1999","journal-title":"Ann Surg"},{"key":"10.1053\/j.seminoncol.2007.05.006_bib23","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1002\/1097-0142(19811015)48:8<1705::AID-CNCR2820480803>3.0.CO;2-4","article-title":"Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil","volume":"48","author":"Moertel","year":"1981","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2007.05.006_bib24","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0360-3016(91)90091-H","article-title":"5-Fluorouracil modulation of radiosensitivity in cultured human carcinoma cells","volume":"20","author":"Smalley","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1053\/j.seminoncol.2007.05.006_bib25","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1056\/NEJM199408253310803","article-title":"Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery","volume":"331","author":"O\u2019Connell","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2007.05.006_bib26","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00000421-200104000-00012","article-title":"Protracted venous infusion 5-fluorouracil with concomitant radiotherapy compared with bolus 5-fluorouracil for unresectable pancreatic cancer","volume":"24","author":"Mehta","year":"2001","journal-title":"Am J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2007.05.006_bib27","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1200\/JCO.1985.3.3.402","article-title":"A pilot study of protracted venous infusion of 5-fluorouracil and concomitant radiation therapy","volume":"3","author":"Rich","year":"1985","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2007.05.006_bib28","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0360-3016(97)00493-8","article-title":"Chemo-radiotherapy for localized pancreatic cancer: Increased dose intensity and reduced acute toxicity with concomitant radiotherapy and protracted venous infusion 5-fluorouracil","volume":"40","author":"Poen","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1053\/j.seminoncol.2007.05.006_bib29","first-page":"65","article-title":"Radiosensitization of human solid tumor cell lines with gemcitabine","volume":"23","author":"Shewach","year":"1996","journal-title":"Semin Oncol"},{"key":"10.1053\/j.seminoncol.2007.05.006_bib30","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.ijrobp.2005.01.043","article-title":"Adjuvant gemcitabine and concurrent continuous radiation (45 Gy) for resected pancreatic head carcinoma: A multicenter Belgian phase II study","volume":"62","author":"Demols","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1053\/j.seminoncol.2007.05.006_bib31","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.ijrobp.2004.01.015","article-title":"Adjuvant therapy in pancreatic cancer: Phase I trial of radiation dose escalation with concurrent full-dose gemcitabine","volume":"59","author":"Allen","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1053\/j.seminoncol.2007.05.006_bib32","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0002-9610(03)00051-5","article-title":"Interferon-based adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma","volume":"185","author":"Picozzi","year":"2003","journal-title":"Am J Surg"},{"key":"10.1053\/j.seminoncol.2007.05.006_bib33","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1056\/NEJMoa032295","article-title":"A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer","volume":"350","author":"Neoptolemos","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2007.05.006_bib34","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1056\/NEJMe048002","article-title":"Adjuvant therapy for pancreatic cancer\u2014The debate continues","volume":"350","author":"Choti","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2007.05.006_bib35","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1056\/NEJM200406243502617","article-title":"Chemotherapy for pancreatic cancer","volume":"350","author":"Crane","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2007.05.006_bib36","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1200\/jco.2006.24.18_suppl.4007","article-title":"RTOG 9704 a phase III study of adjuvant pre and post chemoradiation (CRT) 5-FU vs. gemcitabine for resected pancreatic adenocarcinoma","volume":"24","author":"Regine","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2007.05.006_bib37","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1001\/jama.297.3.267","article-title":"Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: A randomized controlled trial","volume":"297","author":"Oettle","year":"2007","journal-title":"JAMA"},{"key":"10.1053\/j.seminoncol.2007.05.006_bib38","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1091-255X(02)00017-3","article-title":"Does neoadjuvant chemoradiation downstage locally advanced pancreatic cancer?","volume":"6","author":"Kim","year":"2002","journal-title":"J Gastrointest Surg"},{"key":"10.1053\/j.seminoncol.2007.05.006_bib39","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1200\/JCO.1998.16.1.317","article-title":"Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: An Eastern Cooperative Oncology Group study","volume":"16","author":"Hoffman","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2007.05.006_bib40","first-page":"1","article-title":"A multi-Institutional phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinoma","volume":"12","author":"Talamonti","year":"2005","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.seminoncol.2007.05.006_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/jco.2005.23.16_suppl.1","article-title":"Erlotinib plus gemcitabine compared to gemcitabine alone in patients with advanced pancreatic cancer","volume":"23","author":"Moore","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2007.05.006_bib42","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s00262-004-0581-1","article-title":"Phase I study of a MUC1 vaccine composed of different doses of MUC1 peptide with SB-AS2 adjuvant in resected and locally advanced pancreatic cancer","volume":"54","author":"Ramanathan","year":"2005","journal-title":"Cancer Immunol Immunother"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775407001017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775407001017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,25]],"date-time":"2020-04-25T16:33:05Z","timestamp":1587832385000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775407001017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S0093775407001017"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2007.05.006","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}